AbstractViral hepatitis B and Viral hepatitis C are one of the leading causes of disease and death in the
present-day world. These viruses greatly affect the liver by causing inflammation, cirrhosis, fibrosis,
hepatocellular carcinoma (HCC) and even causes the death of affected individuals. It requires highly
cautious treatment to resolve complications associated with it, including abnormal levels of
serological molecules of specific antigens, antibodies and liver enzymes. The treatment involves
the use of antiviral agents that fight against viral antigens, reverses the progression of the disease
and also prevents morbidity. Further reading takes towards the development of safe and effective
antiviral agents and other regimens for lessening complications and ensuring patient compliance.
Moreover, vaccines are also available that fight against the virus and act to prevent the emergence
of viral hepatitis. Future developments are today in clinical trials to produce safer and efficacious
agents to combat and prevent this disease.
1-Marriam Zahid Undergrad Student, Department of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan.2-Ayesha Hamid Undergrad Student, Department of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan.3-Aleenah Asad Undergrad Student, Department of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan.4-Mubashar Rehman Assistant Professor, Department of Pharmacy, Quaid I Azam University, Islamabad, Pakistan.
KeywordsHepatitis, Disease, Hepatitis B, Hepatitis C, Infection, Infection Control, Treatment
Volume & IssueII - I